CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Noncontrolling Interest [Member]	Total
Balance at Sep. 30, 2019	$ 1,208	$ 255,962,922	$ (256,805,589)	$ (7,040)	$ (848,499)
Balance (in shares) at Sep. 30, 2019	1,207,993
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued in public offering, net of offering costs	$ 2,285	10,527,745			10,530,030
Common stock issued in public offering, net of offering costs (in shares)	2,285,000
Deemed dividend - warrant repricing		2,842	(2,842)
Stock based compensation expense		205,490			205,490
Net loss			(2,662,711)	(30)	(2,662,741)
Balance at Dec. 31, 2019	$ 3,493	266,698,999	(259,471,142)	(7,070)	7,224,280
Balance (in shares) at Dec. 31, 2019	3,492,993
Balance at Sep. 30, 2020	$ 5,144	275,548,737	(269,835,650)	(8,725)	$ 5,709,506
Balance (in shares) at Sep. 30, 2020	5,142,779				5,142,779
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of warrants	$ 519	2,605,010			$ 2,605,529
Exercise of warrants (in shares)	518,551
Fair value of warrants issued in connection with convertible note repayment		1,643,440			1,643,440
Stock based compensation expense		571,498			571,498
Net loss			(4,809,556)	2,494	(4,807,062)
Balance at Dec. 31, 2020	$ 5,663	$ 280,368,685	$ (274,645,206)	$ (6,231)	$ 5,722,911
Balance (in shares) at Dec. 31, 2020	5,661,330				5,661,330